i would love to see a distribution deal for PMS than a t/o deal. I don't think management will be in a hurry to sell the company either. With two positive products I assume we need not be sold. We are going to be ATM teller machine for holders. Looking at success of Daybue and good management I assume we are here for long haul. Sp can easily be in twenties by 2026 and with another approval I assume mid thirties can still be on card. Donot forget we are on cups of another phase 3 trial as well. Best part I find is expenses are to a base minimum which provides us a lot of leverage as compared to other biotech companies. I am a late joiner with NEU party but looks like it is never late here. dyor
NEU Price at posting:
$11.00 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)